Min.Order / FOB Price:Get Latest Price
1 Kilogram |
Negotiable |
Sacubitril + Valsartan LCZ696 936623-90-4
We are very compeitive on Sacubitril + Valsartan.Our mfr is GMP certified for this item with WC document.
LCZ696 , a first-in-class inhibitor of dualacting angiotensin-2 type-I receptor and neprilysin inhibitors, was developed as a molecule composed of molecular moieties of valsartan and neprilysin inhibitor prodrug AHU377 in a 1:1 ratio. Several phase 2 randomised clinical trials have been done or are underway in patients with hypertension. In a proof-of-concept randomised trial, LCZ696 was compared with valsartan in 1328 patients with mild-to-moderate hypertension, and provided fully additive reduction of blood pressure. No cases of angio-oedema were reported in the 8 week treatment period. This tolerance should be confirmed, particularly in black patients, for whom omapatrilat resulted in a higher occurrence of angio-oedema than in white patients. Indeed, in the proof-of-concept trial only about 8% of patients were black. |
Product Name: | LCZ696 |
Synonyms: | Sacubitril mixture with Valsartan |
CAS: | 936623-90-4 |
MF: | C48H58N6O8 |
MW: | 847.03 |
Product Categories: | Cardiovascular Series;Inhibitors;API |
CAS NO:489-84-9
CAS NO:70-18-8
CAS NO:910463-68-2
CAS NO:129499-78-1
CAS NO:298-12-4
CAS NO:96702-03-3
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View